Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 4/20 | 0.51 |
| ▸ | NOS1 | P29475 | 4/20 | 0.51 |
| ▸ | NOS2 | P35228 | 4/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.46 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.46 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL302495 | 1.00 | NOS3 (0.51) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| Hydrochloric Acid SCHEMBL30019097 | 0.98 | NOS1 (0.50) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| Methane SCHEMBL3379702 | 0.98 | NOS3 (0.50) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| SCHEMBL30571193 | 0.98 | NOS3 (0.50) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| Hydrogen Sulfide SCHEMBL28096276 | 0.98 | NOS3 (0.50) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| Acetic Acid SCHEMBL30975324 | 0.98 | NOS3 (0.50) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| Methane SCHEMBL3379696 | 0.98 | NOS3 (0.50) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| SCHEMBL4289326 | 0.96 | NOS3 (0.49) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| Homoserine SCHEMBL26118620 | 0.92 | NOS3 (0.46) | NOS3NOS1NOS2SLC1A3SLC1A2 | |
| Cysteine SCHEMBL15312673 | 0.91 | PTGS1 (0.57) | NOS3NOS1NOS2SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081266-A | Recombinant O-acetyl-L-homoserine sulfhydryl transferase mutant, recombinant genetic engineering bacterium and application | — | 2026-05-26 | — | — | CN | claimed |
| CN-122038497-A | Method for improving fermentation efficiency of O-acetyl-L-homoserine | 浙江工业大学 | 2026-05-15 | — | — | CN | claimed |
| US-12534747-B2 | Microorganism producing L-amino acid and method of producing L-amino acid using the same | CJ CHEILJEDANG CORPORATION (KR) | 2026-01-27 | — | — | US | claimed |
| EP-4678760-A1 | MICROORGANISM HAVING INCREASED ACTIVITY OF PYRUVATE DEHYDROGENASE COMPLEX SUBUNIT E1, AND METHOD FOR PRODUCING O-ACETYLHOMOSERINE OR DERIVATIVE THEREOF BY USING SAME | CJ Cheiljedang Corporation (KR) | 2026-01-14 | — | — | EP | claimed |
| US-12522808-B2 | Modified polypeptide with attenuated activity of citrate synthase and method for producing L-amino acid using the same | CJ Chieljedang Corporation (KR) | 2026-01-13 | — | — | US | claimed |
| US-20260002183-A1 | ENZYMATIC METHOD FOR PRODUCING L-GLUFOSINATE AND ITS PHOSPHOESTERS | EVONIK OPERATIONS GMBH (DE) | 2026-01-01 | — | — | US | claimed |
| EP-4667575-A1 | MICROORGANISM WITH ENHANCED PYRUVATE DEHYDROGENASE COMPLEX DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE ACTIVITY AND METHOD FOR PRODUCING L-AMINO ACIDS USING SAME | CJ CheilJedang Corporation (KR) | 2025-12-24 | — | — | EP | claimed |
| US-20250361478-A1 | O-ACETYL HOMOSERINE-PRODUCING MICROORGANISM AND METHOD FOR PRODUCING O-ACETYL HOMOSERINE OR L-METHIONINE USING SAME | CJ CHEILJEDANG CORPORATION (KR) | 2025-11-27 | — | — | US | claimed |
| US-12473558-B2 | Promoter and use thereof | CJ CHEILJEDANG CORPORATION (KR) | 2025-11-18 | — | — | US | claimed |
| US-12378584-B2 | Methionine analogue synthesis | ENGENES BIOTECH GMBH (AT) | 2025-08-05 | — | — | US | claimed |
| US-20060270013-A1 | Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways | METABOLIC EXPLORER (FR) | 2006-11-30 | — | — | US | claimed |
| US-20060223149-A1 | Methods for producing sulphurous fine chemicals | BASF AKTIENGESELLSCHAFT | 2006-10-05 | — | — | US | claimed |
| US-20060068476-A1 | Method for the production by fermentation of sulphur-containing fine chemicals (metf) | EVONIK OPERATIONS GMBH (DE) | 2006-03-30 | — | — | US | claimed |
| US-20060003425-A1 | Method for zymotic production of fine chemicals (meta) containing sulphur | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-05 | — | — | US | claimed |
| EP-1597364-A2 | METHOD FOR THE PRODUCTION OF EVOLVED MICROORGANISMS WHICH PERMIT THE GENERATION OR MODIFICATION OF METABOLIC PATHWAYS | Metabolic Explorer (FR) | 2005-11-23 | — | — | EP | claimed |
| CN-1653186-A | Method for the fermentative production of sulfur-containing fine chemicals using metH-encoding coryneform bacteria | BASF AG (DE) | 2005-08-10 | — | — | CN | claimed |
| WO-2004076659-A2 | METHOD FOR THE PRODUCTION OF EVOLVED MICROORGANISMS WHICH PERMIT THE GENERATION OR MODIFICATION OF METABOLIC PATHWAYS | METABOLIC EXPLORER (FR) | 2004-09-10 | — | — | WO | claimed |
| WO-2004021981-A2 | METHODS FOR THE PREPARATION OF β-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-18 | — | — | WO | claimed |
| US-20030113882-A1 | Methods for the preparation of beta-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-06-19 | — | — | US | claimed |
| WO-1993017112-A1 | BIOSYNTHESIS OF METHIONINE USING A REDUCED SOURCE OF SULFUR | GENENCOR INTERNATIONAL, INC. (US) | 1993-09-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534747-B2 | Microorganism producing L-amino acid and method of producing L-amino acid using the same | MTR, TST, AADAT | NOS3 1474/4885NOS1 963/4885NOS2 914/4885 |
| US-20260002183-A1 | ENZYMATIC METHOD FOR PRODUCING L-GLUFOSINATE AND ITS PHOSPHOESTERS | PGLS, GLO1, GLUL | NOS3 3752/4885NOS1 3387/4885NOS2 3673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.